Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SynCo Bio Partners, a contract manufacturer of biopharmaceuticals, has announced that one of its customers, PaxVax, has received FDA approval for Vaxchora™, a single-dose oral, live attenuated cholera vaccine, indicated for use in adults 18 to 64 ...
read more
Thursday, December 19, 2024
Scinai Immunotherapeutics Ltd., a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced the establishment of a U.S.-...
read more
LabCorp has received approval from the FDA for the UltraQual Multiplex PCR Assay for HCV, HIV-1, HIV-2 and HBV for screening of donated blood plasma.
read more
Wednesday, August 23, 2017
GNS Healthcare has raised an additional $6 million in equity from Amgen Ventures with participation from existing investor Alexandria Real Estate Equities.
read more
Wednesday, February 19, 2020
Biocept has entered into an agreement with a California-based IPA to provide its liquid biopsy testing services to physicians and patients in their network.
read more
Thursday, December 19, 2019
WindMIL has entered into a research collaboration with Bristol-Myers Squibb to evaluate MILs in combination with Opdivo in patients with locally advanced unresectable or metastatic NSCLC.
read more
Bioscript, a full-service pharmaceutical communications company, announced two strategic acquisitions that strengthen and extend its integrated service offering. Fortis Pharma Consulting, a London-based specialist in medical affairs services, brings ...
read more
Monday, September 25, 2017
Jaguar Health announced its wholly-owned subsidiary, Napo Pharmaceuticals, has entered into a Termination, Asset Transfer and Transition Agreement with India-based Glenmark Pharmaceuticals.
read more
Seqens will open a 366,000-square-foot lab today that is close to Paris and will serve as the company’s center of excellence in its Porcheville facility.
read more
YPrime announced the release of its fourth-generation eCOA platform, which is designed to promote data integrity, accuracy and completeness through a feature-rich user experience, domain expertise support and data visibility for sponsors.
read more
Omeros and Lonza announced a long-term manufacturing agreement for commercial production of narsoplimab, also referred to as OMS721.
read more
Calyx, an eClinical and Regulatory solutions and services provider announced the availability of Calyx Supply Simulation, a clinical trial supply forecasting service available through Calyx's in-house expert statistical design and trial supplies ...
read more
Thursday, December 07, 2023
ValGenesis Inc., a leading provider of enterprise validation lifecycle management systems (VLMS), has joined forces with Acumen Analytics, a provider of intelligent digital transformation services, to deliver cutting-edge risk management solutions ...
read more
The Society for Clinical Research Sites (SCRS) is proud to announce the launch of the Global Impact Partnership (GIP) Program. In just over a month, twelve organizations have joined SCRS’ commitment to research site’s success. SCRS Global Impact ...
read more
Monday, November 25, 2019
Luminer has completed an expansion of its primary manufacturing facility in Lakewood, NJ.
read more